Impact BioMedical (IBO) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$35,000.00

Revenue (quarter)

$3,000.00

Revenue growth (year over year)

−57.14%

Gross profit (trailing twelve months)

−$389,000.00

Gross margin

−1111.43%

Net income (trailing twelve months)

$778,000.00

Net income (quarter)

−$700,000.00

Net income growth (year over year)

+95.12%

Net margin

2222.86%

Return on equity

372.24%

EPS (trailing twelve months)

$0.88

Book value per share

$0.10

P/E (trailing twelve months)

62.38

Price to book

3.52

Debt to assets

16.32%

Payout ratio

—

Dividend yield

—

• Is Impact BioMedical (IBO) profitable?

  Yes. Impact BioMedical earned $778,000.00 in net income over the trailing twelve months, a net margin of 2222.86%.

• How much revenue does Impact BioMedical (IBO) make?

  Impact BioMedical generated $35,000.00 in revenue over the trailing twelve months, down 57.14% year over year.

• What is IBO's P/E ratio?

  Impact BioMedical trades at 62.4 times trailing twelve-month earnings, on an EPS of $0.88.

• How do I buy stock in Impact BioMedical (IBO)?

  IBO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.